DE69106276T2 - Säureadditionssalze einer optisch aktiven Alaninanilidverbindung und diese enthaltende, pharmazeutische Zusammensetzungen. - Google Patents

Säureadditionssalze einer optisch aktiven Alaninanilidverbindung und diese enthaltende, pharmazeutische Zusammensetzungen.

Info

Publication number
DE69106276T2
DE69106276T2 DE69106276T DE69106276T DE69106276T2 DE 69106276 T2 DE69106276 T2 DE 69106276T2 DE 69106276 T DE69106276 T DE 69106276T DE 69106276 T DE69106276 T DE 69106276T DE 69106276 T2 DE69106276 T2 DE 69106276T2
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
acid addition
optically active
compositions containing
addition salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69106276T
Other languages
English (en)
Other versions
DE69106276D1 (de
Inventor
Tetsuhide Kamijo
Toshiaki Yamaguchi
Kazuhiko Ikegami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kissei Pharmaceutical Co Ltd
Original Assignee
Kissei Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co Ltd filed Critical Kissei Pharmaceutical Co Ltd
Publication of DE69106276D1 publication Critical patent/DE69106276D1/de
Application granted granted Critical
Publication of DE69106276T2 publication Critical patent/DE69106276T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69106276T 1990-08-08 1991-08-07 Säureadditionssalze einer optisch aktiven Alaninanilidverbindung und diese enthaltende, pharmazeutische Zusammensetzungen. Expired - Fee Related DE69106276T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2211208A JP2514855B2 (ja) 1990-08-08 1990-08-08 光学活性なアラニンアニリド誘導体の酸付加塩

Publications (2)

Publication Number Publication Date
DE69106276D1 DE69106276D1 (de) 1995-02-09
DE69106276T2 true DE69106276T2 (de) 1995-05-18

Family

ID=16602123

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69106276T Expired - Fee Related DE69106276T2 (de) 1990-08-08 1991-08-07 Säureadditionssalze einer optisch aktiven Alaninanilidverbindung und diese enthaltende, pharmazeutische Zusammensetzungen.

Country Status (13)

Country Link
EP (1) EP0472325B1 (de)
JP (1) JP2514855B2 (de)
KR (1) KR100192531B1 (de)
AT (1) ATE116296T1 (de)
AU (1) AU646276B2 (de)
CA (1) CA2048714A1 (de)
DE (1) DE69106276T2 (de)
DK (1) DK143991A (de)
ES (1) ES2066363T3 (de)
FI (1) FI101700B (de)
HK (1) HK1003787A1 (de)
HU (1) HU213210B (de)
NO (1) NO913004D0 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320273D0 (en) * 1993-04-01 1993-11-17 Fisons Corp Compound useful in therapy
ZA942140B (en) * 1993-04-01 1994-10-03 Fisons Corp Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy
CA2748235A1 (en) 2008-12-24 2010-07-01 Astrazeneca Ab Ethanamine compounds and their use for treating depression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE786875A (fr) * 1971-07-28 1973-01-29 Astra Pharma Prod Amide, methode pour sa preparation et ses compositions therapeutiques
US4696930A (en) * 1985-04-12 1987-09-29 Hoffmann-La Roche Inc. N-(heteroarylalkyl)acylanilide derivatives as antiarrhythmic agents
JPS6452797A (en) * 1987-01-06 1989-02-28 Takeda Chemical Industries Ltd Production of crystalline trh-tartrate

Also Published As

Publication number Publication date
AU646276B2 (en) 1994-02-17
EP0472325B1 (de) 1994-12-28
FI913774A0 (fi) 1991-08-08
JPH0495072A (ja) 1992-03-27
HUT58292A (en) 1992-02-28
KR920004334A (ko) 1992-03-27
DK143991D0 (da) 1991-08-07
DK143991A (da) 1992-02-09
FI913774A (fi) 1992-02-09
FI101700B1 (fi) 1998-08-14
DE69106276D1 (de) 1995-02-09
HU213210B (en) 1997-03-28
ES2066363T3 (es) 1995-03-01
EP0472325A2 (de) 1992-02-26
CA2048714A1 (en) 1992-02-09
ATE116296T1 (de) 1995-01-15
KR100192531B1 (ko) 1999-06-15
JP2514855B2 (ja) 1996-07-10
HU912640D0 (en) 1992-01-28
AU8145891A (en) 1992-02-13
NO913004D0 (no) 1991-08-01
FI101700B (fi) 1998-08-14
EP0472325A3 (de) 1992-03-04
HK1003787A1 (en) 1998-11-06

Similar Documents

Publication Publication Date Title
DK338187A (da) 13beta-milbemycinderivater samt deres fremstillingog anvendelse
FI96947C (fi) Menetelmä terapeuttisesti aktiivisten N1-(1,2-cis-2-halogeenisyklopropyyli)substituoitujen pyridonikarboksyylihappojohdannaisten valmistamiseksi
BR8902929A (pt) Artigo vendavel
NO952624D0 (no) Antihyperglykemisk aktivt legemiddel
DE69106276D1 (de) Säureadditionssalze einer optisch aktiven Alaninanilidverbindung und diese enthaltende, pharmazeutische Zusammensetzungen.
NO158622C (no) Analogifremgangsmaate for fremstilling av benzosyrederivater med antimikrobiell aktivitet.
ATE27270T1 (de) Thioester von acetylsalicylsaeure, ein verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DK364386D0 (da) 1-alkyl-ergolinyl-thiourinstofderivater og fremgangsmaade til fremstilling deraf samt deres anvendelse
ES8800144A1 (es) Procedimiento de obtencion de un tioester de la n-acetilcisteina y de sus sales de interes terapeutico
DE69011174D1 (de) Catecholaminester.
AU572374B2 (en) Azolyl-aroxymethyl-dimethylpentinols, their use as fungicides

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee